2024 Fundamentals and Advances in Immunotherapy in the Oncology Patient for the Advanced Practice Provider — On Demand


2024 Fundamentals and Advances in Immunotherapy in the Oncology Patient for the Advanced Practice Provider — On Demand Banner



Date & Location
Thursday, February 15, 2024, 8:00 AM - Saturday, November 30, 2024, 11:00 PM

Specialties
Specialties - Allergy and Immunology, Bone Marrow Transplant, Breast Medical Oncology, Cellular Therapeutics, Critical Care, Dermatology, Endocrinology, Diabetes and Metabolism, Gastrointestinal Oncology, Genitourinary Oncology, Gynecologic Oncology, Head and Neck Oncology, Hepatology, Hospice and Palliative Medicine, Immunotherapy, Leukemia, Lymphoma, Medical Oncology, Neurology, Neuro-Oncology, Nurse Practitioner, Nursing, Oncology and Hematology, Pharmacology and Medication Management, Physician Assistant, Radiation Oncology, Rheumatology, Solid Tumor Oncology

Overview

We're delighted to extend an on demand option for the 2024 Fundamentals and Advances in Immunotherapy in the Oncology Patient course, originally held live on January 24, 2024.

Immunotherapeutics has changed the landscape of treatment modalities available to the cancer patient in both solid tumor and hematologic malignancies. Since the breakthrough of ipilimumab, there have been fast-paced and ongoing advancements in the field of immunotherapy, revolutionizing clinical management at a rapid pace.

This on demand program reviews fundamental concepts and recent advances in immunotherapy designed to meet the learning needs of advanced practice providers (APPs) and other allied health professionals. Clinical application in solid tumor and hematologic malignancies is addressed as well as toxicity management, including immune-related adverse events resulting from immune checkpoint inhibition. Experts discuss fundamentals of immune checkpoint blockade and CAR T cell therapy, as well as advancements in TIL and BITE therapy, novel combination therapy, and algorithmic management of immune-related adverse events. Toxicity management is communicated through case study applications and demonstration of common, rare, and severe immune-related adverse events. View the brochure from the live program to see a complete list of lectures available in this on demand offering.

The overall goal of this program is to improve cancer patient outcomes by advancing the science, development, and application of cancer immunology and immunotherapy through fundamental understanding and clinical application.

The target audience includes nurse practitioners, physician assistants, certified registered nurse anesthetists, physicians, and nurses who care for oncology patients. We are pleased to offer complimentary registration for nursing students and registrants residing in low and lower-middle income countries.

Objectives
At the conclusion of this on demand, learners will be able to:

  1. Describe the principles surrounding the immunity cycle
  2. Explain fundamental principles of immunotherapeutic agents including immune checkpoint inhibition, CAR T cell, TIL, and BITE therapies.
  3. Discuss the symptoms of Cytokine release Syndrome, ICANS, prolonged cytopenias and clinical management
  4. Recognize and identify common, rare, and severe immune related adverse events attributed to immune checkpoint inhibition
  5. Discuss clinical application of immune modulated agents in the oncology population

Registration

Upon successful registration, access to the course materials, including instructions for claiming credit, is located under the 'Course Content' tab. This on demand program will be available for purchase until August 30, 2024. For those that purchase this on demand, access to the content, as well as the opportunity to claim credit, is available through November 30, 2024.

On Demand Access Fees

  • Physicians (MDs, PhDs, and DOs): $249
  • Advanced Practice Providers: $199
  • Nursing and Other Healthcare Professionals: $149
  • Residents, Fellows, and APP Students: $25
  • Nursing Students and Registrants in Low-and Lower-Middle-Income Countries: Complimentary
  • MSK Employees: Complimentary

Nursing Students and Registrants in Low-and Lower-Middle-Income Countries: We are pleased to offer complimentary registration to nursing students along with registrants residing and practicing in low and lower-middle income countries as defined by The World Bank. If you qualify for complimentary registration, please submit a request here for a complimentary promotion code to use at registration.

MSK Employees: Employees of MSK can register for any CME program on a complimentary basis. Please register for this course using your SS0 login credentials.

MSK Alumni and MSK Cancer Alliance Members: A discounted registration rate is offered to MSK Alumni and MSK Cancer Alliance members for all CME programs at MSK. If you belong to either of these groups, please submit a request here to receive a promotion code to be applied at registration. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Recorded/Review Date: January 24, 2024 | Original Release Date: February 15, 2024 | Termination Date: November 30, 2024


Keywords: AMA PRA Category 1